ketoconazole has been researched along with Disease in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 5.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 1.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viviani, MA | 1 |
| Tortorano, AM | 1 |
| Langer, M | 1 |
| Almaviva, M | 1 |
| Negri, C | 1 |
| Cristina, S | 1 |
| Scoccia, S | 1 |
| De Maria, R | 1 |
| Fiocchi, R | 1 |
| Ferrazzi, P | 1 |
1 other study available for ketoconazole and Disease
| Article | Year |
|---|---|
Experience with itraconazole in cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptoc | 1989 |